If you take a GLP-1 medicine, give your pharmacist the exact brand and form plus a list of what you actually take. The main decisions are whether another medicine raises your risk of low blood sugar, needs a timing or monitoring plan, overlaps with your new treatment, or has a specific restriction in the label.
A pharmacy call before a new prescription is filled can save another call when both medicines are already at home. Ask what the combination requires and who will handle any change. Keep taking your medicines as directed while you seek advice, unless your care team or Medication Guide tells you otherwise.
Which items on your medicine list need a closer look?
| What you take | What to ask |
|---|---|
| Insulin or a sulfonylurea such as glipizide | “Can this combination raise my risk of low blood sugar? What should I monitor, and who adjusts my diabetes treatment if needed?” |
| Levothyroxine or another oral medicine with specific timing or monitoring requirements | “How should I take these in the same day? Do I need any follow-up tests or a check on how well the medicine is working?” |
| A hormonal contraceptive pill | “Does the label for this GLP-1 give instructions for starting or changing the dose?” |
| A previous GLP-1 prescription that is still active | “Which is my last dose of the old medicine, and when does the new one start?” |
| Foundayo with a new prescription, or if you already take simvastatin | “Can you check the Foundayo drug-specific restrictions before I take these together?” |
Does another diabetes medicine always mean a low blood sugar risk?
The U.S. labels for Ozempic and Zepbound warn that insulin and medicines that stimulate insulin release, such as sulfonylureas, can increase the risk of hypoglycemia, including severe episodes. A prescriber may need to adjust the other medicine. Tell the diabetes team if your meals have become smaller or less predictable, and ask when to check your glucose. Metformin can be part of an intended combination, as it was in Ozempic trials. Find out which of your drugs drives the extra risk. Use your care plan for a low and see how to respond to GLP-1-related low blood sugar for the separate treatment question. Ozempic U.S. prescribing information · Zepbound U.S. prescribing information
Could an oral medicine need more than a new time on the clock?
GLP-1 medicines can slow stomach emptying, which can change the absorption of some medicines taken by mouth. In a study described in the Wegovy prescribing information, exposure to thyroid hormone increased when levothyroxine was taken with oral semaglutide. The label also advises considering closer clinical or laboratory monitoring for certain oral medicines. If you take thyroid medicine on waking, bring your actual breakfast and medication times. Ask for a schedule that respects both prescriptions and whether you need any thyroid follow-up. Use the oral Wegovy morning guide for that tablet's instructions.
What changes if you take a contraceptive pill?
Mounjaro and Zepbound advise people using oral hormonal contraception to switch to a non-oral method or add a barrier method for four weeks after starting and four weeks after each dose increase. The Foundayo label gives the same choices for 30 days after starting and 30 days after each increase. Those instructions depend on the exact product. Tell the pharmacist when you started or last changed the dose, and ask what the instruction means for the contraceptive you use. For a separate decision about trying to conceive, see planning a pregnancy on GLP-1 treatment.
Who should check a newly prescribed medicine?
Ask the pharmacist who will fill it to review it against your current list before you start. When a walk-in clinic or urgent care prescribes something, show them the GLP-1 carton or portal label during the visit. Include nonprescription products and supplements. If you use more than one pharmacy, bring the list yourself so the review includes medicines dispensed elsewhere.
Foundayo (orforglipron) illustrates why a product-specific check matters. Its U.S. label, sections 2.2 and 7 limits Foundayo to 9 mg once daily with a strong CYP3A4 inhibitor and says to avoid strong inhibitors that also inhibit the transporter OATP1B, such as ritonavir. It advises avoiding strong CYP3A4 inducers and limits simvastatin to 20 mg once daily when the two are taken together. The pharmacist can identify which category applies and contact the prescriber about an alternative, dose change, or monitoring plan. If you find that you already take one of these combinations, ask for timely advice about the next doses.
What if two GLP-1 prescriptions are still on your list?
A refill reminder can arrive after your prescriber intended you to switch. Wegovy, Zepbound, and Foundayo each advise against taking another GLP-1 receptor agonist alongside them. Wegovy and Zepbound also specify other products that contain the same active ingredient. Show the team both labels, the date of your last dose, and whether you still have medicine at home. Ask them to write down which prescription is active and when it begins. Wegovy U.S. label · Zepbound U.S. label · Foundayo U.S. label
What should you have in writing after the review?
For each item, bring its name, form and dose, when you really take it, and any recent start or change. A photo of the full label can help for a supplement or combination cold remedy. Mark older medicines you no longer take as stopped.
Leave with a specific next action and a person to contact. “Pharmacist will call the prescriber before I start the new tablet” tells you more than “interaction found.” For monitoring, record what will be checked and when. Reuse the list when a medicine changes, even for a short course.

About the author
Maya Lee
Glowise Senior GLP-1 Content Editor
Maya Lee is a Glowise Health Content Editor. Her guides turn product records, authoritative sources, and everyday organization questions into clear, practical GLP-1 information.
She helps readers ask better questions and keep the details relevant to a care conversation together.
See more Glowise on Google
Add Glowise as a preferred source to find our GLP-1 guides more easily in Google Search.



